Steven B. Brugger
Fondatore presso Affinivax, Inc.
Profilo
Steven B.
Brugger is the founder of Affinivax, Inc. (founded in 2014), where he holds the title of President, Chief Executive Officer & Director.
He is currently the President & Chief Operating Officer at Strategic Science & Technologies LLC since 2013.
Mr. Brugger's former positions include Chief Executive Officer & Director at Visterra, Inc. (2012-2013), Vice President at Millennium Pharmaceuticals, Inc. (1999-2002), and Chief Operating Officer at Momenta Pharmaceuticals, Inc. (2002-2010).
He also held positions at Novartis Pharmaceuticals Corp., Aventis, Inc., and Abbott Diagnostics, Inc. Mr. Brugger has an MBA from Rutgers State University of New Jersey and an undergraduate degree from Susquehanna University.
Posizioni attive di Steven B. Brugger
| Società | Posizione | Inizio |
|---|---|---|
Strategic Science & Technologies LLC
 Strategic Science & Technologies LLC Pharmaceuticals: MajorHealth Technology Strategic Science & Technologies LLC operates as a clinical stage biotechnology company which develops and distributes pharmaceutical products. It offers KNOSIS, a platform technology that enables pharmaceutical and life science companies to deliver pharmaceutical agents transdermal for the treatment of a host of conditions. The company was founded by Eric T. Fossel and Charles F. Ferris in 2004 and is headquartered in Cambridge, MA. | Presidente | 01/01/2013 |
Affinivax, Inc.
 Affinivax, Inc. BiotechnologyHealth Technology Affinivax, Inc. operates as a biotechnology company which develops novel conjugation technology. The company is headquartered in North Cambridge, MA. | Fondatore | 01/06/2014 |
Precedenti posizioni note di Steven B. Brugger
| Società | Posizione | Fine |
|---|---|---|
| VISTERRA INC | Presidente | 15/07/2013 |
| MOMENTA PHARMACEUTICALS, INC. | Direttore operativo | 05/11/2010 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/08/2002 |
Abbott Diagnostics, Inc.
 Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - |
| Aventis, Inc. | Corporate Officer/Principal | - |
Formazione di Steven B. Brugger
| Susquehanna University | Undergraduate Degree |
| Rutgers State University of New Jersey | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| Aventis, Inc. | |
Abbott Diagnostics, Inc.
Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA. | Health Technology |
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
Strategic Science & Technologies LLC
Strategic Science & Technologies LLC Pharmaceuticals: MajorHealth Technology Strategic Science & Technologies LLC operates as a clinical stage biotechnology company which develops and distributes pharmaceutical products. It offers KNOSIS, a platform technology that enables pharmaceutical and life science companies to deliver pharmaceutical agents transdermal for the treatment of a host of conditions. The company was founded by Eric T. Fossel and Charles F. Ferris in 2004 and is headquartered in Cambridge, MA. | Health Technology |
Affinivax, Inc.
Affinivax, Inc. BiotechnologyHealth Technology Affinivax, Inc. operates as a biotechnology company which develops novel conjugation technology. The company is headquartered in North Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Steven B. Brugger